15th Annual Specialty and Rare Disease Therapies

15th Annual Specialty and Rare Disease Therapies is organized by CBI - an Advanstar and will be held during Jan 25 - 26, 2018 at Las Vegas, Nevada, United States of America.

The target audience for this medical event is consultants, pharmaceutical, medical device and biotechnology companies, infusion centers, group purchasing organizations or technology providers.

Course Description:
The 15th Annual Specialty and Rare Disease Therapies Forum convenes health plans, PBMs, pharmacies and pharmaceutical companies to share timely innovation for managing specialty and rare disease therapies.

Conference Objectives are :
• Understand how pharmacies leverage networks to provide medications they may not have access to
• Learn key concepts to assist your plan in getting the most out of your 340B pharmacy relationships
• Hear a Washington Update on changes to the Affordable Care Act
• Latest advancements in integrating the medical and pharmacy benefit
• Take a deep dive into site-of-care optimization
• Establish tools to manage utilization such as ePrior Authorizations and formulary exclusions
• Review the importance of a quality insurance verification and benefit investigation of your patients and how that impacts the access, economics and maintenance of their Oral Oncolytic Prescription
• Examine real-world therapy management program response to PCSK9 medications
• Adapt programs and value-based design strategies to manage the high costs of pharmaceuticals
• Identify trends in formulary design
• Analyze the biosimilars pipeline and anticipate access barriers
• Compare drug channels for rare disease therapies
• Discuss trends in orphan drug FDA approval and pipeline

Additional details will be posted as soon as they are available.